BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6153736)

  • 1. Inhibition of thyroid cathepsin D activity by pepstatin.
    Starling JR; Hopps BA
    J Surg Res; 1980 Jan; 28(1):8-13. PubMed ID: 6153736
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
    Kay J; Afting EG; Aoyagi T; Dunn BM
    Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain distribution of cathepsin D activity: its inhibition in vivo following central infusion of pepstatin in the rat.
    Buccafusco JJ; Goldstein BD; Greenbaum LM
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):157-60. PubMed ID: 7079582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle.
    Iodice AA
    Life Sci; 1976 Nov; 19(9):1351-8. PubMed ID: 11385
    [No Abstract]   [Full Text] [Related]  

  • 5. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
    Greenbaum LM; Sutherland JH; Narayan TK
    Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of human cathepsin D with the inhibitor pepstatin.
    Knight CG; Barrett AJ
    Biochem J; 1976 Apr; 155(1):117-25. PubMed ID: 938470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of Triiodothyronine-induced tadpole tail-fin regression by cathepsin D-inhibitor pepstatin.
    Seshimo H; Ryuzaki M; Yoshizato K
    Dev Biol; 1977 Aug; 59(1):96-100. PubMed ID: 302228
    [No Abstract]   [Full Text] [Related]  

  • 8. Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.
    Matthews IT; Decker RS; Hornebeck W; Knight CG
    Biochem J; 1983 Apr; 211(1):139-47. PubMed ID: 6347185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cathepsin D by synthetic oligopeptides.
    Lin TY; Williams HR
    J Biol Chem; 1979 Dec; 254(23):11875-83. PubMed ID: 500680
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.
    Knight CG; Hornebeck W; Matthews IT; Hembry RM; Dingle JT
    Biochem J; 1980 Dec; 191(3):835-43. PubMed ID: 6793037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to prevent degeneration of insect muscles with pepstatin.
    Lockshin RA
    Life Sci; 1975 Aug; 17(3):403-10. PubMed ID: 1160510
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of thyrotropin, phorbol esters, norepinephrine, and carbachol on iodide organification in dog thyroid slices, follicles, and cultured cells.
    Rani CS; Field JB
    Endocrinology; 1988 May; 122(5):1915-22. PubMed ID: 2452073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin, carbachol, and protein kinase-C stimulators on glucose transport and glucose oxidation by primary cultures of dog thyroid cells.
    Haraguchi K; Rani CS; Field JB
    Endocrinology; 1988 Sep; 123(3):1288-95. PubMed ID: 2456912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepstatin, an inhibitor of acid kininogenases and ascites retardant in neoplastic disease.
    Greenbaum LM
    Fed Proc; 1979 Dec; 38(13):2788-91. PubMed ID: 92421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of growth in cultured rat thyroid cells.
    Dere WH; Rapoport B
    Mol Cell Endocrinol; 1986 Mar; 44(3):195-9. PubMed ID: 2420657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine secretion by isolated hog thyroid cells: a cyclic AMP independent pathway.
    Rousset B; Munari Y; Rostagnat A; Mornex R
    Mol Cell Endocrinol; 1977 Nov; 9(1):33-43. PubMed ID: 201515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system.
    Mori M; Tajima K; Oda Y; Matsui I; Mashita K; Tarui S
    Endocrinology; 1989 Mar; 124(3):1365-9. PubMed ID: 2465138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.